twofi portrait

Probiotic Innovation: New Application Hopes

e4e1e521-f5fb-49a6-ae2d-c0452dd285fdarticleimage.jpg

03 Aug 2017 --- Michael Bush, President & CEO of probiotic ingredient supplier Ganeden, discusses challenges and opportunities in the probiotic market and the company’s latest innovations.

To contact our editorial team please email us at editorial@cnsmedia.com

Ganeden, Inc.

Collapse

GanedenBC30® (Bacillus coagulans GBI-30, 6086) probiotic is a patented, organism that can be found in more than 900 food, beverage and companion animal products throughout the world. GanedenBC30 is highly stable through processing, shelf life and stomach acids. It is backed by over 25 published studies and approved in over 60 countries. GanedenBC30 is part of Kerry’s nutrition and wellness portfolio.

Related Articles

Health & Nutrition News

Probiotic use associated with fewer antibiotic prescriptions: study

20 Sep 2018 --- Healthy infants and children who take probiotics as a preventative measure receive fewer antibiotic prescriptions, a scientific paper published in European Journal of Public Health reports. The findings are of particular interest considering the growing global demand for ways to reduce antibiotic use, given the urgent public health threat of antibiotic resistance. 

Health & Nutrition News

Adapting to the market? Adaptogens thrive on natural and health trends, but marketing remains a challenge

20 Sep 2018 --- Products that are clean label, natural and have health benefits are in vogue, and busy lifestyles are putting a spotlight on foods and beverages that can offer some stress relief and mood balancing effects. It’s no wonder then that adaptogens – claimed to stabilize physiological processes and promote homeostasis – are having a moment. Featured in a growing number of product categories, suppliers tip ongoing research into their capabilities as well as consumer education as necessary for continued growth.

Health & Nutrition News

Early life microbiome health may have lasting effect on ability to fight disease, study finds

19 Sep 2018 --- The first bacteria introduced into the gut during infanthood may have a lasting impact on an individual’s long-term ability to fight chronic disease, findings from the University of Alberta have suggested. The findings could pave the way for treatments that could adjust microbiomes in infants right after birth to help ward off serious chronic diseases. Poor gut health has been linked to obesity, Type 2 diabetes, heart disease, inflammatory bowel disease, colon cancer, neurological disorders, autism and allergies.

Health & Nutrition News

Coca-Cola enters kombucha category with acquisition of Australia's MOJO brand

19 Sep 2018 --- The Coca-Cola Company has acquired kombucha maker Organic & Raw Trading Co., which makes the MOJO brand of naturally fermented, live culture, organic kombucha drinks. Kombucha is a fast growing beverage category, boosted by growing consumer interest in natural and gut-boosting refreshments. The terms of the agreement have not been disclosed. This is the first time Coca-Cola has acquired full ownership of a brand in the kombucha category, signaling its intent to offer healthy beverages for all occasions.

Health & Nutrition News

ASEAN health and wellness boom spurs Australian innovation potential: CSIRO and KPMG

18 Sep 2018 --- The ASEAN region’s growth prospects and market conditions, coupled with an increased interest in health & wellness, have created a fertile ground for Australian food innovators and companies to do business in the region, according to a report by Australia’s Commonwealth Scientific and Industrial Research Organisation (CSIRO) and professional service company KPMG.

More Articles
URL : http://www.nutritioninsight.com:80/news/probiotic-innovation-new-application-hopes.html